SE9803398D0 - "New use" - Google Patents

"New use"

Info

Publication number
SE9803398D0
SE9803398D0 SE9803398A SE9803398A SE9803398D0 SE 9803398 D0 SE9803398 D0 SE 9803398D0 SE 9803398 A SE9803398 A SE 9803398A SE 9803398 A SE9803398 A SE 9803398A SE 9803398 D0 SE9803398 D0 SE 9803398D0
Authority
SE
Sweden
Prior art keywords
cis
socs
screen
compounds
recombinant
Prior art date
Application number
SE9803398A
Other languages
English (en)
Inventor
Gunnar Norstedt
Egnell Petra Tollet
Morales Amilcar Flores
Original Assignee
Sahltech Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sahltech Ab filed Critical Sahltech Ab
Priority to SE9803398A priority Critical patent/SE9803398D0/sv
Publication of SE9803398D0 publication Critical patent/SE9803398D0/sv
Priority to EP99956433A priority patent/EP1121457B1/en
Priority to PCT/SE1999/001788 priority patent/WO2000020624A1/en
Priority to AU13046/00A priority patent/AU771281B2/en
Priority to DE69919558T priority patent/DE69919558D1/de
Priority to AT99956433T priority patent/ATE274067T1/de
Priority to JP2000574716A priority patent/JP2002526120A/ja
Priority to CA002343651A priority patent/CA2343651A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/61—Growth hormones [GH] (Somatotropin)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SE9803398A 1998-10-06 1998-10-06 "New use" SE9803398D0 (sv)

Priority Applications (8)

Application Number Priority Date Filing Date Title
SE9803398A SE9803398D0 (sv) 1998-10-06 1998-10-06 "New use"
EP99956433A EP1121457B1 (en) 1998-10-06 1999-10-06 Use of socs-2 or cis to screen for compounds enhancing growth hormone effect
PCT/SE1999/001788 WO2000020624A1 (en) 1998-10-06 1999-10-06 Use of socs-2 or cis to screen for compounds enhancing growth hormone effect
AU13046/00A AU771281B2 (en) 1998-10-06 1999-10-06 Use of SOCS-2 or CIS to screen for compounds enhancing growth hormone effect
DE69919558T DE69919558D1 (de) 1998-10-06 1999-10-06 Verwendung von socs-2 oder cis zum 'screenen' von substanzen, die einen wachstumshormoneffekt verstärken
AT99956433T ATE274067T1 (de) 1998-10-06 1999-10-06 Verwendung von socs-2 oder cis zum 'screenen' von substanzen, die einen wachstumshormoneffekt verstärken
JP2000574716A JP2002526120A (ja) 1998-10-06 1999-10-06 成長ホルモン効果を大きくする化合物をスクリーニングするためのｓｏｃｓ−２またはｃｉｓの使用
CA002343651A CA2343651A1 (en) 1998-10-06 1999-10-06 Use of socs-2 or cis to screen for compounds enhancing growth hormone effect

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9803398A SE9803398D0 (sv) 1998-10-06 1998-10-06 "New use"

Publications (1)

Publication Number Publication Date
SE9803398D0 true SE9803398D0 (sv) 1998-10-06

Family

ID=20412847

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9803398A SE9803398D0 (sv) 1998-10-06 1998-10-06 "New use"

Country Status (8)

Country Link
EP (1) EP1121457B1 (sv)
JP (1) JP2002526120A (sv)
AT (1) ATE274067T1 (sv)
AU (1) AU771281B2 (sv)
CA (1) CA2343651A1 (sv)
DE (1) DE69919558D1 (sv)
SE (1) SE9803398D0 (sv)
WO (1) WO2000020624A1 (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE395926T1 (de) * 1999-11-16 2008-06-15 Inst Medical W & E Hall Tiermodell für hormonsignalstudien und verfahren zum verändern der signalübertragung
AU784277B2 (en) * 1999-11-16 2006-03-02 Walter And Eliza Hall Institute Of Medical Research, The An animal model for studying hormone signalling and method of modulating the signalling
AU2002950745A0 (en) * 2002-08-13 2002-09-12 The Walter And Eliza Hall Institute Of Medical Research A method and agents useful for same
FI3827838T3 (fi) 2015-12-16 2023-06-19 Walter & Eliza Hall Inst Medical Res Sytokiini-indusoidun sh2-proteiinin estäminen nk-soluissa

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0948522T3 (da) * 1996-11-01 2008-09-22 Inst Medical W & E Hall Terapeutiske og diagnostiske midler, der kan modulere cellulær fölsomhed over for cytokiner

Also Published As

Publication number Publication date
CA2343651A1 (en) 2000-04-13
ATE274067T1 (de) 2004-09-15
AU771281B2 (en) 2004-03-18
DE69919558D1 (de) 2004-09-23
EP1121457A1 (en) 2001-08-08
JP2002526120A (ja) 2002-08-20
AU1304600A (en) 2000-04-26
EP1121457B1 (en) 2004-08-18
WO2000020624A1 (en) 2000-04-13

Similar Documents

Publication Publication Date Title
CY1107821T1 (el) Πολυπεπτιδιο παραγοντα viii με ενεργοτητα παραγοντα viii:c
ATE413386T1 (de) Ppar-gamma modulatoren
DK0675951T3 (da) Enzym med endoglucanaseaktivitet
ATE227739T1 (de) Hybridprotein zur hemmung der mastzelldegranulation und dessen verwendung
ATE310098T1 (de) Dna kodierend für glutaminsäure-gesteuerte chloridkanäle
IS5959A (is) Aðferð til hástigstjáningar virkra lífvessaeiturefnis-ß-þegaónæmisglóbúlínshermiprótína og hreinsunar þeirra
WO2000066730A3 (en) Laminin 2 and methods for its use
DE69702705T2 (de) Kondensierte pyrrolo(2,3-c) carbazole-6-one die die aktivität von gamma interferon potenzieren
ATE135371T1 (de) Mit akuter pankreatitis assoziiertes protein, mittel zur diagnose von akuter pankreatitis
AR069892A1 (es) Furina recombinante libre de proteinas sustancialmente animal y metodos para producirla. composicion.
ATE233557T1 (de) Verwendung von konjugiertes linolensäure zur steigerung der aktivität von natural killer- lymphozyten
EP0787207A4 (en) NEW METHOD FOR FINDING AND EVALUATING BIOLOGICALLY ACTIVE MOLECULES
DE69924009D1 (de) Methode zur verstärkung der biologischen aktivität von liganden
PT1200561E (pt) Clone celular recombinante estavel, sua producao e utilizacao
SE9803398D0 (sv) "New use"
DE69433902D1 (de) Neuartige tyrosinkinase
DE69734596D1 (de) "smoothened" proteine aus wirbeltieren
BG104769A (en) Modulators of the function of receptors of the tnf/ngf receptor family and other proteins
ATA53397A (de) Reagens zur bestimmung der aptt
ITRM920809A1 (it) Interleuchina-6 mutante con attivita' biologica migliorata rispetto all'interleuchina-6 selvatica.
DE69826029D1 (de) Acetyl-coa-carboxylase von candida albicans
PT1007647E (pt) Expressao de ingap em niveis elevados
GB0006537D0 (en) Assays and screening methods
DE60020970D1 (de) Monoklonaler antikörper mit selektiver bindung an vgf und verwendung zur behandlung von vgf-erkrankungen
CA2359256A1 (en) Propagation of bovine coronavirus in chinese hamster ovary cells